Cantor Fitzgerald analyst Ross Osborn reiterates Pacific Biosciences (NASDAQ:PACB) with a Overweight and maintains $3.5 price target.
- Headlines
- Cantor Fitzgerald Reiterates Overweight on Pacific Biosciences, Maintains $3.5 Price Target
Cantor Fitzgerald Reiterates Overweight on Pacific Biosciences, Maintains $3.5 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
09:01
FTSE Straits Times Index opened up by about 0.2%, SATS, seatrium rose by over 1%, Singtel, Citydev, DBS Group Holdings, JMH USD, Keppel Corp and other rose slightly.
FTSE Singapore Straits Time Index+0.27%
09:00
In November, the logistics price index for highways in china was 104.6 points.
09:00
The ftse china a50 index futures opened down 0.21%, and closed down 0.16% on the previous trading day night session.
FTSE China A50 Index+0.61%